Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JCS/JSCVS/JCC/CVIT 2023 guideline focused update on indication and operation of PCPS/ECMO/IMPELLA.

Journal of cardiology·2024
Same author

CORRIGENDUM: JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLA.

Circulation journal : official journal of the Japanese Circulation Society·2024
Same author

JCS/JSCVS/JCC/CVIT 2023 Guideline Focused Update on Indication and Operation of PCPS/ECMO/IMPELLA.

Circulation journal : official journal of the Japanese Circulation Society·2024
Same author

Severe Left Ventricular Failure Unmanageable by Impella 5.0.

Cureus·2023
Same author

JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure.

Circulation journal : official journal of the Japanese Circulation Society·2022
Same author

Perforation of the right atrial appendage during implantation of a leadless pacemaker.

Journal of arrhythmia·2022
Same journal

[Secondary Pneumothorax due to Rupture of Pulmonary Rheumatoid Nodule:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Thoracoscopic Right Upper Lobectomy for Lung Cancer with Tracheal Bronchus:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Neoplastic Cardiac Tamponade Manifesting as Left Ventricular Diastolic Dysfunction:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Non-anastomotic Pseudoaneurysm due to Sternal Wire Removal After Ascending Aorta Grafting:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Successful Staged Total Aortic Replacement in a Young Patient with Marfan Syndrome:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Massive Left Ventricular Thrombus Following Steroid Therapy for Immunoglobulin( Ig) G4-related Ophthalmic Disease:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

[Ventricular assist device].

Shunei Kyo1, S Takamoto

  • 1Department of Therapeutic Strategy for Heart Failure, Tokyo University, Tokyo, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|August 19, 2010
PubMed
Summary
This summary is machine-generated.

The latest artificial heart technology in Japan includes implantable ventricular assist devices (VADs). Newer generations show promise for long-term durability and improved patient outcomes in end-stage heart failure.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Experiment Videos

Last Updated: Jun 10, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Medical Device Technology

Context:

  • End-stage heart failure necessitates advanced treatment options.
  • Japan's market currently offers paracorporeal ventricular assist devices (VADs).
  • Historically, implantable VADs and total artificial hearts (TAHs) have seen limited clinical use in Japan.

Purpose:

  • To review the current landscape of artificial heart devices in Japan.
  • To evaluate the clinical performance of implantable VADs under investigation.
  • To highlight the potential of next-generation VADs for long-term patient support.

Summary:

  • Japan is evaluating four implantable VADs: HeartMate XVE, Jarvik 2000, Evaheart, and DuraHeart.
  • Early clinical results indicate promising survival rates and patient recovery with these devices.
  • Second and third-generation non-pulsatile VADs, like DuraHeart, are anticipated to offer superior durability and reduced complications.

Impact:

  • Advancements in VAD technology offer new hope for patients with end-stage heart failure awaiting transplantation.
  • The development of durable, effective VADs can significantly improve quality of life and long-term prognosis.
  • Successful clinical evaluation of next-generation VADs may lead to wider adoption and improved treatment paradigms.